WILMINGTON, Mass. — Kapa Biosystems announced that Color Genomics, a leader in affordable genetic risk testing for breast and ovarian cancer, has implemented Kapa’s high-performance library construction reagents into its NGS workflow. The reagents provide a fully automatable, streamlined process, saving time and allowing Color to return results faster to healthcare providers. Color Genomics offers […]
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Noridian Healthcare Solutions, LLC, a Medicare Administrative Contractor (MAC) for two Medicare jurisdictions covering 13 states, has issued favorable final local coverage determinations (LCDs) for the Prosigna® Breast Cancer Assay, effective for services […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that it has entered into a long-term agreement with Thermo Fisher Scientific under which HTG will have the right to develop a number of in-vitro diagnostic (IVD) tests for use with Thermo Fisher’s next-generation sequencing […]
Lyon and Toulouse, France, – Novasep, a leading supplier of services and technologies for the life sciences industry, and GTP (Gene-to-Proteins) Technology, a CDMO providing recombinant protein and process development services, today announce a partnership that combines their expertise in monoclonal antibodies (mAbs) production. The partners aim to facilitate the development of therapeutic and diagnostic […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO) announced the launch of its EGFR C797S Mutation Detection Assay based on the company’s ICE COLD-PCR™ (ICP) technology. This new test detects the presence of the EGFR C797S mutation that is associated with resistance to new third-generation tyrosine kinase inhibitor (TKI) therapies in development for non-small cell lung […]
SHENZHEN; SHANGHAI; CAMBRIDGE, Massachusetts; and REYKJAVIK, – Huawei, a leading global information and communications technology provider, and WuXi AppTec, the global open-access R&D platform, have announced the signing of a strategic framework agreement to support the China Precision Medicine Initiative (China PMI) through the creation of a state-of the-art precision medicine cloud platform. The agreement […]
Hilden, Germany, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced that QuantiFERON®-TB Gold, the modern standard for accuracy in diagnosing latent tuberculosis (TB) infection, was selected by the Taiwan Centers for Disease Control (Taiwan CDC) to replace the tuberculin skin test for screening at-risk individuals five years and older. Starting this month, Taiwan’s […]
CARPINTERIA, Calif. — Agilent Technologies Inc. (NYSE: A), a worldwide provider of cancer diagnostics through its Dako Pathology Solutions division, announced that it has published “Breast Cancer Diagnosis: Past, Present and Future,” a white paper on the use of immunohistochemistry in diagnosing and treating breast cancer. The white paper was made available at a gathering […]
CASTLE ROCK, Colo. — Venaxis®, Inc. (Nasdaq: APPY), announced today that Venaxis, Strand Life Sciences Private Limited (Strand LS) and its U.S. subsidiary Strand Genomics Inc. (SGI), have agreed to terminate the previously announced transactions between the companies. On March 11, 2016, Venaxis, Strand LS and SGI entered into a Mutual Termination Agreement to terminate […]
Renishaw Diagnostics Ltd, a subsidiary of FTSE 250 listed Renishaw plc, has won funding from Innovate UK to accelerate development of a diagnostic assay that will identify patients carrying bacteria resistant to an important last line in antibiotic therapy. The development contract, worth £150,000, has been awarded as part of a £10M, two-phase competition to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
